EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation

Nguyen Van Truong iD, Tuyet-Kha Nguyen, Nguyen Sy Thau iD, Thi-Thanh Hang Chu, Jin-Hee Han, Sung-Hun Na, Won-Sun Park, Wan-Joo Chun iD, Joo Hwan No, Feng Lu, Robert W Moon iD, Eun-Taek Han iD

Antimicrobial Agents and Chemotherapy · 04.11.2026 · 70 (11)

DOI: 10.1128/aac.00382-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 04.11.2026. Verfasst von Nguyen Van Truong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Medicine, Kangwon National University School of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea. Hauptthemen laut MEDLINE: Antimalarials, Proteasome Inhibitors, Plasmodium falciparum. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Regional Innovation System & Education (RISE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of novel anti-malarial drugs has become urgent due to increasing drug resistance. Our previous work identified ONX-0914, which targets parasite proteolytic systems, as promising against Plasmodium falciparum . This study aims to further evaluate the antiplasmodial activity of ONX-0914 and related proteasome inhibitors (PIs) against various Plasmodium strains. The in vitro antimalarial activity of the inhibitors was evaluated against the Plasmodium knowlesi A1H1 strain and compared with that against the chloroquine (CQ)-sensitive P. falciparum 3D7 strain. Potent synergistic interactions between compounds and artemisinin (ART) were analyzed against PkA1H1 and ART-resistant PfDd2R539T(+) using an isobologram. To explore the mode of action, the disruption of the ubiquitin-proteasome system (UPS) in PkA1H1 and Pf3D7 was investigated. In vivo efficacy of ONX-0914 was further validated against CQ-resistant Plasmodium yoelii . PIs significantly inhibited PkA1H1 proliferation with low-nanomolar IC 50 values; ONX-0914 and LU-005i were more potent against PkA1H1 than Pf3D7, and effectively blocked multiple blood stages. Inhibition of parasite growth correlated with potent disruption of UPS at nanomolar concentrations (IC 50 < 50 nM). ONX-0914 demonstrated strong synergistic activity with ART and other PIs (∑FIC50 < 0.8). In vivo , ONX-0914 significantly suppressed P. yoelii infection, improving lifespan, with ⁓84% efficacy at an intraperitoneal (IP) dose of 20 mg/kg, and ⁓90% in combination with artemisinin at a dose of 10 mg/kg (IP). Further optimization of the structure and dosing regimen is able to enhance the therapeutic potential of PIs as potential antimalarial drug candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsProteasome InhibitorsPlasmodium falciparumAnimalsChloroquineDrug ResistanceMiceArtemisininsPlasmodium yoeliiPlasmodium knowlesiDrug SynergismMalariaHumansProteasome Endopeptidase Complex

Stichwörter der Autor:innen

ONX-0914Plasmodiumantimalarial drugproteasome inhibitor

Substanzen

AntimalarialsProteasome InhibitorsChloroquineArtemisininsartemisininProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Tropical Medicine, Kangwon National University School of Medicine, Chuncheon-si, Gangwon-do, Republic of Korea.
  • Department of Infectious Diseases, 103 Military Hospital, Hanoi, Vietnam.
  • Institute of Clinical Infectious Diseases, 108 Military Central Hospital, Hanoi, Vietnam.
  • Department of Obstetrics and Gynecology, Kangwon National University School of Medicine, Chuncheon, Gangwon-do, Republic of Korea.
  • Department of Physiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
  • Department of Pharmacology, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.

ORCID-Profile: Nguyen Van Truong, Nguyen Sy Thau, Wan-Joo Chun, Robert W Moon, Eun-Taek Han

Förderung

  • National Research Foundation of Korea
  • Regional Innovation System & Education (RISE)

Zitieren

APA

Van Truong, N., Nguyen, T. K., Sy Thau, N., Chu, T. T. H., Han, J. H., Na, S. H., Park, W. S., Chun, W. J., No, J. H., Lu, F., Moon, R. W., & Han, E. T. (2026). Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation. Antimicrobial Agents and Chemotherapy, 70(11). https://doi.org/10.1128/aac.00382-26

Vancouver

Van Truong N, Nguyen TK, Sy Thau N, Chu TTH, Han JH, Na SH, et al. Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation. Antimicrobial Agents and Chemotherapy. 2026;70(11). doi:10.1128/aac.00382-26

BibTeX
@article{VanTruong2026,
  author = {Van Truong, Nguyen and Nguyen, Tuyet-Kha and Sy Thau, Nguyen and Chu, Thi-Thanh Hang and Han, Jin-Hee and Na, Sung-Hun and Park, Won-Sun and Chun, Wan-Joo and No, Joo Hwan and Lu, Feng and Moon, Robert W and Han, Eun-Taek},
  title = {Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {11},
  doi = {10.1128/aac.00382-26}
}
Kostenlos starten →